4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-058954
VP, Clinical Trial Operations sold 32,535 shares at an average $13.16 ($428,180)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-15 | Sale : show line 1 in the form | −26,732 | $12.94 | $345,915 | 5,803 | D |
| 2023-12-15 | Sale : show line 2 in the form | −5,803 | $14.18 | $82,265 | 0 | D |
| Open-market sales · 32,535 sh · avg $13.16 · $428,180 | ||||||
Loading xslF345X05/doc4.xml…